These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A qualitative evaluation of a comprehensive self-management programme for COPD patients: effectiveness from the patients' perspective. Monninkhof E; van der Aa M; van der Valk P; van der Palen J; Zielhuis G; Koning K; Pieterse M Patient Educ Couns; 2004 Nov; 55(2):177-84. PubMed ID: 15530752 [TBL] [Abstract][Full Text] [Related]
11. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. Wixner J; Sundström T; Karling P; Anan I; Suhr OB BMC Gastroenterol; 2015 Apr; 15():51. PubMed ID: 25908211 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study. Deux JF; Damy T; Rahmouni A; Mayer J; Planté-Bordeneuve V Amyloid; 2014 Dec; 21(4):246-55. PubMed ID: 25211144 [TBL] [Abstract][Full Text] [Related]
13. Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy. Algalarrondo V; Antonini T; Théaudin M; Chemla D; Benmalek A; Castaing D; Cauquil C; Rouzet F; Mika D; Duong E; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Adams D; Slama MS Amyloid; 2018 Dec; 25(4):253-260. PubMed ID: 30632809 [TBL] [Abstract][Full Text] [Related]
14. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058 [TBL] [Abstract][Full Text] [Related]
15. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Coelho T; Maurer MS; Suhr OB Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944 [TBL] [Abstract][Full Text] [Related]
16. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615 [TBL] [Abstract][Full Text] [Related]
17. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine. Obayashi K; Tasaki M; Jono H; Ueda M; Shinriki S; Misumi Y; Yamashita T; Oshima T; Nakamura T; Ikemizu S; Anan I; Suhr O; Ando Y Clin Chim Acta; 2013 Apr; 419():127-31. PubMed ID: 23462670 [TBL] [Abstract][Full Text] [Related]
19. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture]. Harada T; Ishizaki F; Togo M; Yamashita H; Nitta K; Date Y; Nakazato M; Yamamura Y; Nakamura S No To Shinkei; 2002 Jul; 54(7):615-9. PubMed ID: 12187722 [TBL] [Abstract][Full Text] [Related]